Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen is a clinical-stage biotechnology company with a promising Enhanced Delivery Oligonucleotide platform that shows potential for improving the effectiveness of oligonucleotide therapeutics in treating various neuromuscular and neurologic diseases. The company's strong financial position with $132M in cash and no change to its previous guidance for 2H27 provides a solid runway for future development. However, with a need for additional external funding and ongoing concerns regarding efficacy and splicing correction assays, PepGen should continue to be cautiously evaluated by investors.

Bears say

PepGen is a clinical-stage biotechnology company that has potential in the field of oligonucleotide therapeutics, but there are several fundamental reasons for a negative outlook on the company's stock. Firstly, the company's pipeline products are still in the preclinical stage, with limited data available on their efficacy and safety. Secondly, the company's FREEDOM2 trial has faced regulatory hurdles, which could delay the timeline for potential commercial launch in the US. Finally, there are concerns about the reliability of the splicing data for PGN-EDODM1, as seen in the company's 5mg/kg MAD cohort. This, along with the competitive landscape in the field, could impact the company's ability to gain traction in the market. Overall, the company's uncertain timeline for potential product approval and potential competitive pressures could negatively impact its long-term prospects as an investment.

PepGen Inc (PEPG) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 6 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.